Please login or register to print this page.

Articles

Browse all our past articles

November 8, 2016

News from the Heart Rhythm Congress 2016

The largest heart rhythm event in the UK – the Heart Rhythm Congress – took place at the International Convention Centre in Birmingham between 9–12th October 2016. This was a unique meeting showcasing the latest developments in arrhythmia care, together with arrhythmia patient day meetings, nurse education and specialist further accreditation for cardiac physiologists. Dr Rahul Mukherjee (Clinical Research Fellow in Cardiac Electrophysiology, Guys and St Thomas’ Hospital Biomedical Research Centre) reports on some of the highlights from this meeting.

read more

November 8, 2016

Healthcare costs and innovative solutions for arrhythmia care

In an increasingly difficult economic climate, it is more important than ever to develop innovative solutions to the rising cost of healthcare. Professor Richard Schilling, President Elect of the British Heart Rhythm Society (Barts Health NHS Trust, London), proposed novel solutions to the rising cost of arrhythmia care during the plenary session. He highlighted the need to simplify the patient journey by empowering paramedics to treat supraventricular tachycardias (SVTs) and reduce hospital admissions; having a national online resource for patients with intelligent information delivery.

read more

November 8, 2016

Improving outcomes from VT ablation

Some of the most innovative technologies being employed to treat patients with ventricular tachycardia (VT) were discussed during this session. Dr Charlotte Manisty (Bart’s Health NHS Trust, London) described the use of peri-procedural imaging using computed tomography (CT) and magnetic resonance imaging (MRI) to create 3D maps of scar in the heart, identify optimal ablation targets and help decide the approach to VT ablation. Some investigators are working on developing interventional cardiac MRI platforms using active and passive tracking catheters to gain real-time information and optimise VT ablation using imaging guidance.

read more

November 8, 2016

NOACs: translating latest clinical and cardioversion data into practice

In the latest ESC 2016 guidelines for the management of patients with atrial fibrillation (AF), it is now a Class 1A recommendation to use a non-vitamin K oral anticoagulant (NOAC) in preference to warfarin where a patient would otherwise be eligible for a NOAC for non-valvular AF. Warfarin is currently still recommended in patients with moderate-to-severe mitral stenosis and mechanical heart valves.

read more

November 8, 2016

Young Investigator Award

‘Lifelong endurance athletes – what is the burden of arrhythmias in this group?’ This was the question addressed by the winner of the Young Investigator Award (Clinical Science) – Dr Ahmed Merghani (St George’s Hospital, London). In an elegant study, he analysed 152 athletes >40 years age with >10 years of endurance exercise with age, sex and ethnicity matched veteran controls (<150 mins exercise/week). All participants underwent a 24hr Holter monitor, cardiac magnetic resonance imaging (MRI) scan and cardiac computed tomography (CT) scan. Interestingly, in veteran athletes, there was a higher incidence of narrow complex tachycardias, pauses >2.5s and runs of non-sustained ventricular tachycardia.

read more

October 19, 2016

News from the ESC 2016

We report the anticoagulation highlights from this key event in the cardiology calendar – the European Society of Cardiology (ESC) Congress – in this special edition of Arrhythmia Watch. Taking place in Rome, Italy, from 27th -31st August 2016, it attracted over 33,000 delegates from across the globe, including His Holiness Pope Francis. Studies selected for the much anticipated Hotline sessions included the ENSURE AF study looking at the use of edoxaban in cardioversion and the ANNEXA-4 study for reversal of acute bleeding.

read more

October 19, 2016

ENSURE AF: edoxaban allows prompt cardioversion in AF

Patients with atrial fibrillation (AF) who need anticoagulation before undergoing cardioversion may benefit from treatment with the non-vitamin K antagonist oral anticoagulant (NOAC), edoxaban, compared to best possible conventional therapy (warfarin and enoxaparin), according to results from the ENSURE-AF study presented during a hotline session at the meeting.

read more

October 19, 2016

Commentary on ENSURE-AF

British Junior Cardiologists Association (BJCA) President, Dr Jubin Joseph, who is also British Heart Foundation Clinical Research Fellow, at St Thomas’ Hospital, London, discussed ENSURE AF in our podcast (click here to view).

read more

October 19, 2016

ANNEXA 4: reversal agent shows efficacy in acute bleeding

Preliminary results in the ongoing ANNEXA-4 study have shown that andexanet can rapidly reverse anti-factor Xa activity in acutely bleeding patients and is associated with excellent or good haemostasis in most.

read more

October 19, 2016

New ESC/EACTS guidelines for the management of AF

The first collaborative ESC and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines on Atrial Fibrillation (AF) were published at the start of ESC Congress.1 These multidisciplinary guidelines focus on early detection of asymptomatic AF, recommending both opportunistic and targeted screening for all patients aged ≥65 years, or with stroke or transient ischaemic attack (TIA).

read more

« Newer articlesOlder articles »

Members Area

Log in or Register now.

 For healthcare professionals only
Angina book sky

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

SPONSORED BY

Pifzer

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.